BAI1 | Brain-specific angiogenesis inhibitor 1 | Cancer-related genes G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
BAI2 | Brain-specific angiogenesis inhibitor 2 | G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
BAI3 | Brain-specific angiogenesis inhibitor 3 | G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
BDKRB1 | Bradykinin receptor B1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
BDKRB2 | Bradykinin receptor B2 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
BRS3 | Bombesin-like receptor 3 | G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
C3AR1 | Complement component 3a receptor 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
C5AR1 | Complement component 5a receptor 1 | CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
C5AR2 | Complement component 5a receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CALCR | Calcitonin receptor | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CALCRL | Calcitonin receptor-like | G-protein coupled receptors Plasma proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
CASR | Calcium-sensing receptor | Disease related genes FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CATSPER1 | Cation channel, sperm associated 1 | Disease related genes Predicted membrane proteins
| | | | | Tissue enriched |
CATSPER2 | Cation channel, sperm associated 2 | Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
CATSPER3 | Cation channel, sperm associated 3 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CCKAR | Cholecystokinin A receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CCKBR | Cholecystokinin B receptor | Cancer-related genes FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
CCR1 | Chemokine (C-C motif) receptor 1 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CCR10 | Chemokine (C-C motif) receptor 10 | Cancer-related genes G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Mixed |
CCR2 | Chemokine (C-C motif) receptor 2 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CCR3 | Chemokine (C-C motif) receptor 3 | CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
CCR4 | Chemokine (C-C motif) receptor 4 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CCR5 | Chemokine (C-C motif) receptor 5 (gene/pseudogene) | CD markers Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
CCR6 | Chemokine (C-C motif) receptor 6 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CCR6 | Chemokine (C-C motif) receptor 6 | Predicted membrane proteins
| | | | | Tissue enhanced |
CCR7 | Chemokine (C-C motif) receptor 7 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CCR8 | Chemokine (C-C motif) receptor 8 | CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CCR9 | Chemokine (C-C motif) receptor 9 | CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
CCRL2 | Chemokine (C-C motif) receptor-like 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
CD97 | CD97 molecule | CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
CDS2 | CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2 | Enzymes Mitochondrial proteins Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CELSR1 | Cadherin, EGF LAG seven-pass G-type receptor 1 | Disease related genes G-protein coupled receptors Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Mixed |
CELSR2 | Cadherin, EGF LAG seven-pass G-type receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CELSR3 | Cadherin, EGF LAG seven-pass G-type receptor 3 | G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CERS1 | Ceramide synthase 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CERS3 | Ceramide synthase 3 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
CERS4 | Ceramide synthase 4 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CERS5 | Ceramide synthase 5 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
CERS6 | Ceramide synthase 6 | Predicted membrane proteins
| | | | | Expressed in all |
CHRM1 | Cholinergic receptor, muscarinic 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CHRM2 | Cholinergic receptor, muscarinic 2 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CHRM3 | Cholinergic receptor, muscarinic 3 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
CHRM4 | Cholinergic receptor, muscarinic 4 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CHRM5 | Cholinergic receptor, muscarinic 5 | FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
CLCNKB | Chloride channel, voltage-sensitive Kb | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
CLN3 | Ceroid-lipofuscinosis, neuronal 3 | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CMKLR1 | Chemokine-like receptor 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Expressed in all |
CNR1 | Cannabinoid receptor 1 (brain) | FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CNR2 | Cannabinoid receptor 2 (macrophage) | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
COQ2 | Coenzyme Q2 4-hydroxybenzoate polyprenyltransferase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |